Back
Summit Therapeutics Stock Predictions
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
SMMT
Summit Therapeutics
Last Price:
19.72
Seasonality Move:
33.87%
7 Day Trial
ALL ACCESS PASS
$
7
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Summit Therapeutics Stock Forecast
- Over the next 52 weeks, Summit Therapeutics has on average historically risen by 115% based on the past 9 years of stock performance.
- Summit Therapeutics has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Summit Therapeutics Stock Undervalued?
The current Summit Therapeutics [SMMT] share price is $18.92. The Score for SMMT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. - SMMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Summit Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Summit Therapeutics has on average historically risen by 115% based on the past 9 years of stock performance.
Summit Therapeutics Stock Rating
Sell
44
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics overpriced?
- Summit Therapeutics has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Summit Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
smmttx.com
52-Week Data
52-Week High:
33.89
52-Week Low:
1.64
Prediction Charts
Market Cap:
13.9B
Price in USD:
18.92
Volume:
2.45M
Beta:
-0.26
Technical Analysis
SMA50:
16.44
SMA100:
12.02
SMA200:
7.96
52-Wk Change:
975%
Stock Predictions
-
Is Summit Therapeutics stock public?
Yes, Summit Therapeutics is a publicly traded company. -
What is the Summit Therapeutics stock quote today?
The Summit Therapeutics stock price is 18.92 USD today. -
How to buy Summit Therapeutics stock online?
You can buy Summit Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-19 | 25.09 | 23.16 | 25.13 | 22.93 |
| Sep-20 | 23.16 | 24.39 | 24.95 | 22.96 |
| Sep-23 | 24.40 | 21.91 | 25.50 | 20.85 |
| Sep-24 | 21.91 | 23.99 | 24.00 | 21.04 |
| Sep-25 | 24.82 | 22.64 | 24.84 | 22.37 |
| Sep-26 | 22.84 | 22.81 | 23.62 | 22.04 |
| Sep-27 | 21.49 | 20.89 | 21.70 | 19.50 |
| Sep-30 | 20.50 | 21.90 | 22.05 | 20.25 |
| Oct-1 | 21.63 | 20.10 | 21.84 | 19.75 |
| Oct-2 | 19.75 | 19.54 | 20.36 | 19.22 |
| Oct-3 | 19.29 | 18.61 | 19.29 | 18.36 |
| Oct-4 | 20.21 | 19.09 | 21.33 | 18.12 |
| Oct-7 | 19.25 | 18.92 | 19.49 | 18.44 |
| Oct-8 | 18.79 | 19.69 | 20.18 | 18.71 |
Summit Therapeutics Earnings
Summit Therapeutics Earnings Report: Per Share Summit Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Summit Therapeutics Forecast Revenue Growth
Summit Therapeutics Stock Analysis: Historical quarterly revenues per share for Summit Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.33 per share, and a decrease next year of $0.03 per share.
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.